Phylogica continues to prove the effectiveness of its lead first generation cell penetrating peptides, or “CPP’s”, after winning its first ever competitive test with a competitor CPP in an animal model. Mice treated with the company’s CPP vaccine before being injected with a highly aggressive melanoma, had a longer survival time compared to those treated with the competing CPP.
08/02/2019 - 11:28
Phylogica peptide vaccine wins competitive shootout
By Matt Birney
08/02/2019 - 11:28
Related Data & Insights
-
-
Rank Company Revenue 87th PYC Therapeutics $15.8m 90th GreenHy2 $15.0m 91st K2fly $14.8m 93rd Advanced Braking Technology $14.7m 94th DTI Group $13.3m 202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
14 Mar 2024
PYC taps investors for $75m
02 Jan 2024
Nedlands company joins Google in AI project
11 May 2023
Perth biotech company raises $30m
07 Nov 2022
Healthtech banks on rising numbers
15 Jul 2022
Exal Group buys $44m Freo warehouse
13 May 2022
Hockings hopes for blindness drug
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX